首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis and Prior External Chest Radiation
【24h】

Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis and Prior External Chest Radiation

机译:经截管主动脉瓣膜置换患者患有症状严重主动脉狭窄和先前的外部胸部辐射

获取原文
获取原文并翻译 | 示例
           

摘要

Background/purpose: Surgical aortic valve replacement (SAW) in patients with symptomatic severe aortic stenosis (AS) and prior chest radiation is associated with poor outcomes in comparison with patients without prior radiation. Our objective was to compare clinical outcomes of patients with and without prior chest radiation undergoing transcatheter aortic valve replacement (TAVR) for symptomatic severe AS. Methods/materials: Between January 2003 and January 2017,1150 patients underwent TAVR at our institution. Of these, 44 had prior chest radiation. Baseline demographic and clinical characteristics, procedural details, and clinical outcomes were prospectively collected. Results: Patients with prior chest radiation were younger, 76 ± 13 years, compared with those without prior chest radiation, 82 ± 8 years (p = 0.002). Median Society of Thoracic Surgeons score for chest radiation patients was 7 ± 4, compared to 8 ± 5 in those without prior radiation. Despite higher prevalence of complete heart block, there was no significant difference between the 2 groups with regard to the need for permanent pacemaker implantation. There was a trend toward longer length of intensive care unit stay in chest radiation patients, but there was no significant difference in 30-day or 1-year mortality. Conclusions: Thus, TAVR appears to be a safe treatment option in the short and medium term for patients with symptomatic severe AS and prior chest radiation.
机译:背景/目的:患有症状严重主动脉狭窄患者的外科主动脉瓣置换(锯)和现有胸部辐射与未经前辐射的患者相比,胸部辐射差。我们的目的是将患者的临床结果进行比较,而无需现有的胸部放射,经历过经膜状管主动脉瓣膜置换(TAVR)以进行症状严重。方法/材料:2003年1月至2017,1150患者在我们的机构接受了TAVR的患者。其中,44有胸部辐射。基线人口统计学和临床​​特征,程序细节和临床结果进行了前瞻性地收集。结果:患有现有胸部辐射的患者较年轻,76±13岁,与没有现有胸部辐射的人相比,82±8年(P = 0.002)。胸部辐射患者的胸外科医生评分中位数为7±4,而在没有先前辐射的情况下为8±5。尽管完全心脏块的普遍率较高,但两组在需要永久起搏器植入方面没有显着差异。在胸部辐射患者中,重症监护单元的长度较长,但30天或1年死亡率没有显着差异。结论:因此,TAVR似乎是患有症状严重和胸部辐射的患者的短期和中期安全治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号